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Several aryldiazonium salts are described as irreversible blockers of the phencyclidine binding site of the 
nicotinic cholinergic receptor. A partial hydrophobic character increases the affinity of these salts for the 
phencyclidine binding site. PhotoaffInity labelling with a tritiated diazonium salt in the presence of either 
carbamylcholine or a-bungarotoxin leads to incorporation of radioactivity into the 4 subunits of the recep- 
tor. Among these diazonium salts, an imidazole derivative is unique in that the photoinduced irreversible 
blocking in only effective when the receptor is in a desensitised state. 
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1. INTRODUCTION 
The acetylcholine receptor of Torpedo electric 
organ is a pentameric omplex composed of 4 dif- 
ferent polypeptides with apparent M, values of 
40000 (cu), 50000 Ca), 60000 (y) and 66000 (6). 
Two m-subunits are present in each pentamer. At 
least 3 pharmacological sites can be distinguished 
in the acetylcholine receptor complex: (i) the 
acetylcholine binding site which complexes other 
agonists and competitive antagonists such as a- 
bungarotoxin and d-tubocurarin; (ii) the non-com- 
petitive binding site able to bind histrionicotoxin, 
phencyclidine and a large variety of molecules 
which share very little, if any, structural homol- 
ogy; (iii) the ionic channel which allows cation 
translocation through the membrane [ 1,2]. 
Whilst the involvement of the 40-kDa subunit in 
Abbreviations: carb, carbamylcholine; cuBgtx, cy- 
bungarotoxin; PCP, phencyclidine; NCB, non-com- 
etitive blocker; AcHR, acetylcholine receptor; DDF, p- 
(N,N-dimethylamino)benzenediazonium fluoroborate 
the acetylcholine binding site on the receptor com- 
plex is clearly demonstrated, localization of the 
non-competitive binding site using photoaffinity 
labelling experiments is more complex to in- 
vestigate. In fact, the labelling pattern is dependent 
on the structure of the photosensitive ligand as well 
as the state (resting, opened or desensitized) and 
the source of the receptor [3,6]. Interpretation of 
experiments, attempting to localise the NCB bind- 
ing site is difficult due to the long-lived photo- 
generated species and/or the poorly understood 
photochemical processes. Thus, the regioselectivity 
of labelling remains uncertain. 
To overcome these difficulties, we synthesized 
aryldiazonium derivatives which are non- 
competitive blockers giving rise to highly reactive 
species upon irradiation (fig. 1). These diazonium 
salts, chemically stable in the dark under 
physiological conditions [7,8], generate with ir- 
radiation one of the most powerful reagents yet 
known, the aryl cation [9]. The properties of some 
of these diazonium salts as photosensitive non- 
competitive blockers of the acetylcholine receptor 
are described here. 
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2. EXPERIMENTAL 
Acetylcholine receptor rich membrane frag- 
ments from Torpedo marmorata were prepared as 
described in [lo]. The concentration of acetyl- 
choline binding sites was measured by equilibrium 
binding [ 11,121. pH 11 treated membranes were 
obtained according to Neubig et al. [13]. 
IlI) 
(11 
R= CH, 
cm) R=nC,H, 
(IS!) R= CH,C,H, 
(Y) RR= 
3 
(YII R= H I COCH, 
All the diazonium salts were synthesized by 
diazotization of the corresponding arylamine with 
sodium nitrite (5% molar excess) in 34% (w/v) 
fluoroboric acid at - 10°C and were recrystallized 
from acetone [ 141. Irradiation experiments were 
done in phosphate buffer (sodium phosphate (pH 
7.2), 10 mM; NaCl, 150 mM) at 10°C in 1 cm 
quartz cell. Reaction mixture contained a given 
concentration of diazonium salts and 500-800 
nmol of 3H-labelled a-toxin binding sites for an 
assay volume of 0.5 ml. 
Monochromatic light was obtained from a 
1000 W xenon mercury lamp connected to a 
grating monochromator. The light beam formed a 
spot 10 mm high and 2 mm wide. Light intensity 
was measured with a thermopile (Kipp and 
Zohnen). 
Dissociation constants of the ligands for the 
agonist binding site were determined by measuring 
the decrease of the binding rate of the Naja 
nigricoilis a-toxin to the receptor rich membrane 
fragments [15,16]. 
Dissociation constants of the ligands for the 
PCP binding site were obtained by competition 
with [3H]PCP towards the receptor rich membrane 
fragments as described in [ 171. Percentage of inac- 
tivation of the PCP binding site in the irreversible 
experiments was calculated from a reference sam- 
ple (membranes and carb or/cuBgtx) irradiated in 
Table 1 
Reversible binding characteristics of diazonium salts ((I)-(VI)) to T. marmoruta receptor rich 
membranes measured in the dark 
Ligand log pexpa Ki,pp (M) 
(a-toxin) 
K, (PCP) (M) 
+ carbamylcholine + a-toxin 
(1O-4 M) 
(I) N.D.b 5 x 1o-3 1.5 + 0.2 x 1om3 1.8 + 0.2 x 1O-3 
(II) -2.3 1o-3 2.5 + 0.3 x 1o-4 1.7 + 0.1 x 1o-4 
(III) -0.1 1o-5 1.6 + 0.2 x 1O-6 4 + 1 x 1o-6 
(IV) +0.3 7 x 1o-5 5 * 1 x 1o-6 - 
(V) - 1.4 1om4 0.7 5 0.1 x 1o-6 0.8 k 0.1 x 1O-6 
(VI) - 1.9 1o-3 2.6 + 0.2 x 1O-5 8 -t 1 x 1O-5 
PCP + 0.9 2.5 x 1O-4 [5] 1.5 k 0.1 x 1o-6 2.6 Z!Z 0.3 x 1O-6 
a Diazonium salts (2 x 10e4 M) are stirred for 30 min in a 1 : 1 mixture of octanol and buffer 
(phosphate, 150 mM; NaCl, 10 mM; pH 7.2) at 4°C. After separation of the two phases the 
partition coefficients PeXp are determined by UV measurements of the concentrations of the 
diazonium salts in the octanol layer 
b Product (I) is not sufficiently soluble in octanol to get reliable results 
The native membranes are preincubated either with aBgtx (2 molar excess for 2 h) or with carb 
(10m4 M for 10 min). After addition of the diazonium derivatives to the incubation medium the 
samples are irradiated as described in section 2 
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the same conditions. The number of PCP binding 
sites is proportional to the number of radiolabelled 
PCP molecules specifically bound to the mem- 
branes when incubated in the presence of a low 
concentration of PCP (1 nM). 
3. RESULTS AND DISCUSSION 
3. I. Aryld~azon~~~ salts as reversible ligands 
Table 1 summarizes the binding characteristics 
in the dark of two different classes of diazonium 
used: one derivative of imidazole (I) and several 
substituted aryldiazonium salts (II-VI) (fig. 1). All 
these compounds are fairly stable in our incuba- 
tion conditions in the absence of light @r/z > 2 h). 
They show affinity for the acetylcholine binding 
site as well as for the PCP high affinity binding 
site, In all cases, a higher affinity (10 times) is 
observed for the last site. Such a phenomenon has 
been noticed with other NCB [S,lS]. 
All experiments were done on the PCP binding 
site in the presence of either atBgtx (native state of 
AcHR) or carb (desensitized state) to prevent bind- 
ing of the diazonium salts to the acetylcholine 
binding site. There is no significant difference in 
the affinities of compounds I or II for the two 
states while compound III, the best ligand of this 
series, binds slightly more efficiently to the desen- 
sitized state. Identical observations have been 
made with PCP and several non-competitive 
blockers [5,19,201. Affinity of the diazonium 
derivatives increases with their hydrophobicity. 
Two observations can be made: (i) product (I), 
which is positively charged and practically insolu- 
ble in octanol, interacts with the PCP binding site 
even though its affinity is low. (ii) Increasing the 
hydrophobicity of the ligand improves its affinity, 
but only to a certain extent since compound (IV) 
which has a higher partition coefficient than com- 
pound (III), has a lower affinity. Thus a positive 
charge and hydrophobicity are two important 
characteristics of compounds showing affinity for 
the NCB binding site. Many products such as 
tricyclic antidepressant [211, perhydrohistrionico- 
toxin 122,233, PCP [5,24,251, triphenylmethyl- 
phosphonium ions [4], local anesthetics [5,20] and 
our derivatives bind with a good affinity to the 
NCB binding site (low7 M < KD < lop5 M) while 
they have no clear structural homology. We inter- 
pret these results proposing the existence in the 
vicinity of the ionic channel of a hydrophobic NCB 
binding area much larger and less specific than a 
binding site. 
3.2. Aryldiazonium salts as irreversible blockers 
of the PCP bindjng site 
Table 2 shows the results of irreversible inactiva- 
tion of the PCP binding site obtained after irradia- 
tion of the receptor rich membranes with different 
diazonium salts in the presence of either carb or 
Table 2 
Irreversible loss of PCP binding capacity of T. marmoraia receptor rich 
membranes 
Ligand Concentration 
used (M) 
Inactivation of PCP binding site in 
the presence of” (c70) 
~arbamylcholine cr-Toxin 
(1O-4 M) 
(1) 2 x 10-3 4ob 0 
(II) 2 x 1o-4 40 40 
(III) 2 x 1o-6 44’ 34 
(IV) 10-s 20 8 
(V) 10-4 40 
a General conditions used: hex = 290 nm, E = 1.32 x 10e7 E.s-i.cm-2, 
C = Ki, 6’ = 4’C, t = 30 min 
bhex = 313 nm 
c C = I/2 K, 
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cYBgtx. In agreement with the high photosensitivity 
of the ligand and the high reactivity of the 
generated aryl cation (lifetime < IO-’ s [27]), we 
can reasonably assume that by irradiation we ob- 
tain an instantaneous picture of the iigand- 
receptor complex in a structure similar to the 
original one. Thus variations in the efficiency of 
the inactivation of the receptor reflect the 
diazonium environment in the binding site, since 
the ligand can react essentially with the target pro- 
tein or with water molecules. When irradiations 
are done under comparable conditions (A,,, = 
290 nm; ligand concentration = Ki) the desensi- 
tized state of the receptor is blocked to the same 
extent by compounds (II), (III) and (V), Com- 
pound (IV), which is more hydrophobic, is less ef- 
ficient, suggesting that it binds to the PCP binding 
site in a different way. 
Comparison of the amount of inactivation bet- 
ween the desensitized and the native states of the 
receptor by compounds (II), (III) and (IV) shows 
no drastic differences. Compound (I) blocks the 
desensitized state of the receptor very efficiently 
(hexc = 313 nm, 50% inactivation at K, concentra- 
tion). This result is remarkable since it is obtained 
in direct photoaf~nity labelling conditions which 
are less efficient than the energy transfer condi- 
tions used for the diazonium (II) to (V) [8,26]. No 
inactivation is observed in the native state; this 
discrimination might be due to structural dif- 
ferences in the receptor-ligand complex. In the 
native state (I) reacts more easily with water than 
with the protein. This could imply either that the 
PCP binding site is more hydrated in the resting 
state or that the positioning of (I) in the binding 
site is different. Whatever the explanation, (I) is an 
efficient label to discriminate between native and 
desensitized states of the receptor. 
3.3. Poiypeptides involved in the NCB binding 
area 
We have determined which chains of AcHR are 
labelled after irreversible binding of a photosen- 
sitive iigand. Despite the relatively low affinity of 
compound (II) (10e4 M), it has been chosen to per- 
form preliminary experiments for the two follow- 
ing reasons: (i) it binds with about the same affini- 
ty to the resting and desensitized states of the 
receptor, and (ii) it blocks irreversibly very effi- 
ciently the PCP binding site in both states. The 
300 
labelling experiments with radioactive compound 
(II) are shown in fig.2. In the presence of car- 
bamylcholine the 4 subunits are labetled. Prior in- 
cubation with unlabelled PCP lowers the radioac- 
tivity incorporated to about 50% of the initial 
value. The same pattern of radioactivity is ob- 
served when the membranes are incubated in the 
presence of tvBgtx (not shown). 
From these resutts several interpretations are 
possible: (i) The binding site is located on one 
subunit and the Iight generated aryl cation diffuses 
out of the site and reacts randomly with residues of 
the surrounding subunits. As discussed previously, 
the high reactivity of this species makes this 
possibility unlikely. (ii) The different subunits 
define a large binding area allowing several orien- 
tations for ligand complexation: such a situation 
was described for cyclodextrin X-complexes [28]. 
Results obtained with aryl diazonium salts are 
promising since they are good NCB of AcHR in 
the dark and are able to block very efficientty the 
PCP binding site under irradiation. Studies with 
radioactive ligand (II) suggest hat the 4 different 
subunits are involved in the PCP binding site. The 
exceptional behaviour of one of them (I) which 
discriminates between the native and the desen- 
X10$ 
dpm 
40K 5OK 60K 66K MW 
Fig.2. ‘H incorporation in the different subunits after 
irradiation of pH 11 treated T. marmorata receptor rich 
membranes in the presence of 10e4 M carb and 2 x 
low4 M [3HJDDF. The radioactivity incorporations are 
determined without PCP (A) and in the presence of 3 x 
IO-' M PCP (B). 
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sitized state of the receptor might be useful 
(especially as a radioactive derivative) for confor- 
mational prospecting of the NCB binding area. To 
our knowledge this is the first example of such a 
discrimination at the reactivity level. 
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